secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001104659-24-074467
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel suspends preferred stock dividend; replaces Board Chair, defers CEO salary
--------------------------------------------------------------------------------

- Suspended quarterly cash dividend on 6% Convertible Exchangeable Preferred Stock (CYCCP) scheduled for Aug 1, 2024; board will evaluate quarterly.
- Dr. Samuel L. Barker appointed Chair of board; Dr. Christopher Henney stepped down as Chair but remains director.
- CEO Spiro Rombotis agreed to defer $22,000/month of salary until Dec 31, 2024; amount forfeited if not paid by then.
- Stockholders approved amendment to 2018 Equity Incentive Plan, reserving additional 160,000 shares of common stock.
- All three Class 3 director nominees (Henney, McBarron, Spiegel) re-elected; RSM US LLP ratified as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/0001104659-24-074467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/tm2418092d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-074467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer